On the final day of the American Stroke Association’s International Stroke Conference 2024, ISC 2024, findings from the EMBOLISE clinical trial were presented by Jason Davies, M.D., Ph.D., an associate professor in the departments of neurosurgery and biomedical informatics at the State University of New York, Buffalo.
News | AHA
ISC 2024 News: Late-Breaking Science Findings from EMBOLISE Clinical Trial Reveals Blocking Artery Supplying the Brain Covering After Subdural Hematoma Reduced Repeat Surgery

February 9, 2024 — Injection of a substance to block an artery feeding the dura (protective sack around the brain) — ...

Home February 09, 2024
Home
Primary effectiveness endpoint results show high revascularization rates of 93.9% mTICI 2b/3
News | Stroke
MIVI Neuroscience Presents Primary Endpoint Results from the EvaQ Trial — at the 2024 International Stroke Conference

February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective ...

Home February 09, 2024
Home
Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. Image by Getty.
News | Structural Heart
Smidt Heart Institute Physicians Advance Transcatheter Tricuspid Valve Replacement

February 9, 2024 — Physicians in the Smidt Heart Institute at Cedars-Sinai have achieved two significant firsts ...

Home February 09, 2024
Home
Meticulously designed rapid exchange catheter now commercially available in the United States
News | Catheter
BIOTRONIK and IMDS Join Forces to Launch Innovative Micro Rx Catheter

February 9, 2024 — BIOTRONIK introduced the Micro Rx catheter, a novel rapid exchange microcatheter developed to easily ...

Home February 09, 2024
Home
The American Heart Association (AHA) has announced it is providing $450,000 in grants to assess its new risk prediction tool among diverse race, age, geographic and socioeconomic groups.
News | AHA
American Heart Association Announces New Scientific Research Will Test PREVENT Risk Calculator Among Diverse Groups

February 8, 2024 — The American Heart Association (AHA), currently celebrating its centennial year, announced that it is ...

Home February 08, 2024
Home
ResearcherLate-breaking science from the American Stroke Association’s International Stroke Conference, ISC 2024, reports researchers found an artificial intelligence (AI) system to help guide treatment decisions for stroke patients led to improved stroke care quality and fewer recurrent strokes, heart attacks and vascular death among stroke survivors three months after a stroke.
News | AHA
International Stroke Conference Researcher Finds AI-based System Helped Guide Treatment, Lowered Stroke Recurrence

February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association’s ...

Home February 08, 2024
Home
Late-breaking science from a multi-center U.S. trial presented during the International Stroke Conference found that a flat head position for stroke patients before surgical removal of a blood clot in the brain (thrombectomy) may lead to better outcomes.
News | AHA
ISC 2024 Late-breaking Science Finding from ZODIAC Study: Position of Head Before Surgery May Improve Stroke Patient’s Neurological Function

February 7, 2024 — According to results from a multi-center trial in the United States, called Zero Degree Head ...

Home February 07, 2024
Home
STROKE AF study shows long-term continuous cardiac monitoring delivers strong economic value driven by fewer projected lifetime strokes
News | Stroke
Medtronic LINQ Insertable Cardiac Monitors Prove Cost-effective Compared to Standard of Care in Ischemic Stroke Patients with Suspected Atrial Fibrillation

February 7, 2024 — Medtronic announced new cost-effectiveness data from the STROKE AF clinical study, which showed that ...

Home February 07, 2024
Home
The brain has about 100 billion cells called neurons. It’s made up of distinct parts, that developed though human evolution. Copyright American Heart Association
News | Stroke
Nerve Stimulation Plus Intense Rehab May Improve Arm and Hand Function After Stroke

February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover ...

Home February 07, 2024
Home
This new document builds off of the previously published Best Practices for Consumer Cardiovascular Technology Solutions in January 2022.
News | ACC
CTA and ACC Collaborate to Tackle Cardiovascular Disease with Technology

February 7, 2024 — The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) are announcing ...

Home February 07, 2024
Home
Findings from the highly-anticipated MOST (Multi-Arm Optimization of Stroke Thrombolysis) trial were presented on the first day of the American Stroke Association’s International Stroke Conference, ISC 2024, being held through Feb. 9 in Phoenix, AZ.
News | AHA
Findings from MOST Trial Presented at ISC24: Blood thinners added to clot-busting medication did not improve stroke outcomes

February 7, 2024 — Researchers presenting preliminary late-breaking science presented on the first day of the American ...

Home February 07, 2024
Home
During the American Stroke Association’s International Stroke Conference 2024, ISC24, eleven scientists leading the way in stroke research will be recognized for their exceptional professional achievements.
News | AHA
American Stroke Association to Honor 11 Leading Scientists at International Stroke Conference ISC 2024

February 7, 2024 — Eleven scientists leading the way in stroke research will be recognized during the American Stroke ...

Home February 07, 2024
Home
New phenomapping tool and clinical score could lead to personalized strategies for patients hospitalized with ADHF
News | Artificial Intelligence
Machine Learning Informs a New Tool to Guide Treatment for Acute Decompensated Heart Failure

February 6, 2024 — A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The ...

Home February 06, 2024
Home
ATTRibute-CM results also demonstrated rapid clinical benefit on the composite endpoint of all-cause mortality (ACM) and CVH in patients treated with acoramidis, with time-to-first event Kaplan-Meier curves separating at month 3 and continuing to diverge steadily through Month 30
News | FDA
BridgeBio Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application (NDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

February 6, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home February 06, 2024
Home
EGF Mapping system aims to improve patient outcomes by enabling precise and personalized ablation strategies
News | Atrial Fibrillation
Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow (EGF) Mapping for use in Atrial Fibrillation Ablation

February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...

Home February 06, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now